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A West Highland White Terrier was presented after
development of hindlimb myoclonus and hyperalgesia
following intended epidural administration of morphine
at a referring veterinary practice. MRI was unremarkable,
except for the spinal cord extending to the caudal half
of the L7 vertebrae. Treatment with systemic analgesia
of methadone and sedation/analgesia with
medetomidine resolved the clinical signs within
24 hours. The mechanism by which morphine causes
adverse neurological side effects has yet to be fully
determined; the morphine-3-glucuronide (M-3-G)
metabolite is suspected to be responsible for the adverse
effects seen. Hypotheses include action of morphine or
the M-3-G metabolite on non-opioid inhibitory (glycine)
or excitatory (N-methyl D-aspartate) receptors. However,
more work is needed to determine the exact
pathogenesis. Neuroexcitatory side effects are rarely
reported following administration of morphine in dogs
and this case demonstrates successful treatment with the
use of an alternative opioid, methadone.
BACKGROUND
Performing epidurals in patients undergoing hind-
limb, tail or perineal surgery is an effective means
of providing analgesia both intraoperatively and
postoperatively. A variety of drugs can be adminis-
tered into the epidural space, but most often com-
binations of local anaesthetics and opioids are used.
Side effects following epidural administration are
fortunately uncommon; this case highlights a rare
but signiﬁcant side effect of intended epidural mor-
phine administration in a dog and outlines a suc-
cessful treatment protocol.
CASE PRESENTATION
An 8.2 kg six-year-old neutered female West
Highland White Terrier was presented to the
University of Liverpool Small Animal Teaching
Hospital following right hindlimb wedge sulco-
plasty and tibial tuberosity transposition performed
by the referring veterinary surgeons. Preanaesthetic
medication at the referring practice was 0.03 mg/kg
acepromazine (Calmivet 5 mg/ml, Vetoquinol
France) and 0.02 mg/kg buprenorphine (Vetergesic,
Alstoe Animal Health) intramuscularly. At the same
time, Meloxicam (Metacam 5 mg/ml solution for
injection, Boehringer Ingelheim) at 0.2 mg/kg and
potentiated amoxicillin at 8.75 mg/kg (Synulox
RTU injection, Pﬁzer Animal Health) were given
subcutaneously. A 22-gauge catheter was placed in
the right cephalic vein. Anaesthesia was induced
with propofol (PropoFlo, Abbott Animal Health)
to effect. The trachea was intubated with a 7.0 mm
endotracheal tube and anaesthesia was maintained
with isoﬂurane vaporised in oxygen via a non-
rebreathing system.
Prior to the start of surgery, the dog was placed
in sternal recumbency and a lumbosacral epidural
was performed with a total of 2.5 mg (0.3 mg/kg)
of undiluted morphine (Morphine sulfate 10 mg/
ml, Wockhardt UK) with sodium metabisulphite as
preservative. For up to 10 minutes after the epi-
dural, mild focal repeated contractions of the tail
were noted, which then resolved spontaneously.
Surgery was performed without complications.
After surgery, as consciousness was regained, the
dog began vocalising violently (described as scream-
ing), repeated rapid muscle contractions between
one to two seconds duration and hypertonicity of
both hindlimbs and tail were noted. Vocalisation
was observed to increase when the hindlimbs or tail
were gently touched. The dog was re-anaesthetised
with intravenous propofol to effect and the trachea
was re-intubated. The dog was transported under
total intravenous anaesthesia with propofol to the
University for investigation and treatment.
INVESTIGATIONS
On arrival at the hospital, the dog was connected
to a non-rebreathing system, and isoﬂurane
vaporised in oxygen was delivered at 4 l/minute to
maintain anaesthesia. Heart rate on admission was
60 bpm, respiratory rate was 16 breaths per
minute, rectal temperature was 34.8°C, palpebral
reﬂex was absent and eyes were rotated ventro-
medially. Muscle tone was ﬂaccid in all four limbs,
but anal tone was present. A forced warm air
blanket (Bair Hugger, Arizant healthcare) was
placed to increase body temperature. Lactated
ringers solution (Hartmann’s solution) was admi-
nistered intravenously at 32 ml/hour. Continuous
monitoring included heart rate, respiratory rate,
end-tidal carbon dioxide, measured via a sidestream
gas analyser and percentage haemoglobin satur-
ation, estimated via a pulse oximeter probe placed
on the tongue using a multiparameter monitor
(Datex ohmeda, GE healthcare). Indirect ossillo-
metric blood pressure was measured at ﬁve-minute
intervals with a cuff placed on the left forelimb
over the palmar metacarpal artery (Cardell veterin-
ary monitor 9401, Paragon medical). Body tem-
perature was measured with a rectal thermometer.
All measured parameters, which the exception of
rectal temperature, were within normal limits
throughout.
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After 20 minutes, isoﬂurane was discontinued, and oxygen
was continued at 4 l/minute. Palpebral reﬂex returned after 10
minutes, swallowing reﬂex was absent, ﬁve minutes later
repeated rapid contractions and of the tail and hindlimb and
hypertonicity of the hindlimb muscles were present, and normal
tone was present in the forelimbs. Withdrawal reﬂex was normal
in the forelimbs but delayed in the hindlimbs. Isoﬂurane
vaporised in oxygen was restarted until palpebral reﬂex was
absent and muscle contraction ceased. The dog was taken for
MRI of the lumbosacral spine. An MRI (Magnetom Harmony
1Tesla scanner, Siemens) was performed with T1 and T2
weighted images, which showed the spinal cord extending to
the caudal half of L7 with the dural sac extending into the
sacrum. There was also moderate dorsal protrusion of the
annulus of L7-S1 intervertebral disc, but no signiﬁcant compres-
sion of spinal cord. Mild foraminal stenosis with no signiﬁcant
compression was noted. No other abnormalities were identiﬁed.
Immediately after removal from the MRI room, heart rate was
58 bpm, respiratory rate was 16 breaths per minute and rectal
temperature had reduced to 33.5°C. Due to lack of clinically sig-
niﬁcant ﬁndings on MRI, it was suspected the hyperalgesia and
neurological abnormalities of the hindlimbs and tail were due to
morphine administration.
TREATMENT
Whilst still anaesthetised, the dog was taken to the intensive
care unit; 0.3 mg/kg of methadone (Comfortan, Eurovet animal
health) and 0.002 mg/kg medetomidine (Sedator, Dechra veter-
inary products) were given intravenously to provide analgesia
and sedation for recovery. As it was most likely that morphine
administration into either the epidural or intrathecal space had
caused the hyperalgesia and hindlimb and tail contractions seen,
alternative analgesia with methadone was given and medetomi-
dine was used to provide additional analgesia and muscle relax-
ation. A forced warm air blanket and electric heating pad
(HotDog, Augustine Temperature Management) were used to
increase patient temperature. Isoﬂurane was discontinued and
oxygen was continued at 4 l/minute for a further 20 minutes.
The trachea was extubated 75 minutes after discontinuation of
isoﬂurane once palpebral reﬂexes and swallowing reﬂex had
returned. Rectal temperature at this time had increased to 35.5°
C. Mild to moderate muscle twitching of both hindlimbs were
present at the time of extubation, and withdrawal was present in
all four limbs. As consciousness was regained, no vocalisation
was noted, the dog appeared calm and not distressed. Once
rectal temperature was 37.0°C and the dog was able to maintain
sternal recumbency without assistance, she was returned to a
kennel. A pain score of 3/20 was recorded using a short form of
the Glasgow composite pain score (Reid and others 2007).
Methadone was continued at 0.3 mg/kg intravenously every
4 hours for 12 hours, and hindlimb muscle twitching reduced in
frequency overnight. Pain score 12 hours after extubation was 2/
24; at this time, there were no neurological abnormalities of the
hindlimbs present and no response to palpation of the hin-
dlimbs and tail was noted. The dog was 9/10 lame at the walk
on the right hindlimb, which was expected following the ortho-
paedic procedure performed. Methadone was continued at
0.3 mg/kg for a further 12 hours and then stopped, and meloxi-
cam (Metacam oral suspension for dogs, Boehringer Ingelheim)
was given per os once daily starting 24 hours after initial injec-
tion. After discontinuation of methadone, buprenorphine
(Vetergesic 0.3 mg/ml, Alstoe animal health) at 0.02 mg/kg was
administered intravenously every 8 hours for 24 hours, after
which point it was stopped.
OUTCOME AND FOLLOW-UP
The dog was discharged from the hospital 48 hours after pres-
entation and showed no further neurological abnormalities
when examined 10 days postsurgery.
DISCUSSION
The spinal cord in dogs normally terminates between L6 and
L7, but occasionally extends to the caudal half of L7 in small
breed dogs, as was observed on the MRI in this patient, with
the dural sac extending into the sacrum (Dyce and others
2002). Epidurals are usually performed at the lumbosacral space
in dogs as this provides the largest area for access to the epidural
space (Valverde 2008). Lumbosacral intrathecal injections can be
performed but it is recommended to reduce the dose of drug
given to a quarter to a half of that normally given epidurally
(Wetmore and Glowaski 2000). It is possible in this case the
injection may have been intrathecal rather than epidural, and
the caudal position of the spinal cord meant that accidental
penetration into the subarachnoid space would have been pos-
sible. The referring veterinary surgeon did not report the pres-
ence of cerebrospinal ﬂuid or blood in the hub of the needle
when performing the procedure, and correct placement of the
needle in the epidural space was reported to be conﬁrmed by
lack of resistance to injection; however, aspiration from the
needle prior to injection of morphine was not performed. It has
previously been shown that accidental intrathecal injection can
occur in dogs positioned in sternal recumbency, even when cere-
brospinal ﬂuid is not detected in the hub of the needle before
injection (Bosmans and others 2011) and aspiration from the
needle is advised prior to injection. The dose given to this
patient was 2.5 mg (0.3 mg/kg), although the recommended epi-
dural dose for morphine is no more than 0.1 mg/kg; at higher
doses than this, side effects are more likely to be seen, with no
improvement in analgesia (Valverde 2008). In the absence of
other ﬁndings on the MRI scan to explain the clinical signs, it
was presumed the neurological abnormalities in this case were
due to administration of morphine into the epidural or sub-
arachnoid space. To the authors’ knowledge, there are no
reports of similar clinical signs in dogs following epidural,
rather than intrathecal, administration of morphine.
Hyperalgesia is deﬁned as an increased sensitivity to pain and
allodynia is a painful response to normally non-noxious stimuli
(Hardy and others 1950), and it can be difﬁcult to distinguish
between the two in canine patients. The presence of hyperalgesia
and/or allodynia in this case was suspected due to increased vocal-
isation on palpation of the hindlimbs and tail. It could be predicted
that pain would be present following orthopaedic surgery of the
right hindlimb, but response to touching the left hindlimb and tail
would not be expected. The response was also thought to be
excessive for the type of surgery performed. Vocalisation, such as
persistent howling or squealing, has been reported in dogs recover-
ing from anaesthesia with isoﬂurane (Love and others 2007, Laing
and others 2009) that had not undergone painful procedures,
making interpretation of these clinical signs somewhat difﬁcult. It
was the clinical opinion of the veterinary surgeon in this case that
the described vocalisation was due to pain rather than emergence
excitement following anaesthesia.
Cases of opioid induced hyperalgesia are well documented in
the literature (Angst and Clark 2006, Koppert 2007) and can be
seen following systemic or spinal administration. It is more com-
monly seen following chronic exposure, but has been reported
in humans and animals following single high doses (Angst and
Clark 2006). Myoclonus, brief, shock-like contractions of a
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muscle or group of muscles, is less common but has been
reported following intrathecal administration of preservative-
free morphine in dogs at normal doses (Kona-Boun and others
2003, Iff and others 2012) and following inadvertent overdose
(Da Cunha and others 2007). Myoclonus with hyperalgesia has
been reported in humans receiving chronic pain management
with repeated large doses of intrathecal morphine (Krames and
others 1985, De Conno and others 1991). Stiffness of the arms
and legs has also been documented after an accidental large
dose of epidural morphine (Atanassoff and Alon 1988) and
myoclonus described following combined epidural and systemic
morphine (Radbruch and others 1997) in human patients.
It is unknown by what exact mechanism these neuroexcitatory
effects occur; however, there are a number of hypotheses. It is
thought that morphine or a metabolite of morphine,
morphine-3-glucuronide (M-3-G), may be responsible (Smith
2000). One proposed mechanism by which morphine or M-3-G
causes neuroexcitation is via antagonism of glycine receptors
within the spinal cord. In a study by Yaksh and others (1986),
rats given high doses of intrathecal morphine, M-3-G or strych-
nine, a glycine receptor antagonist, displayed similar signs of
hyperalgesia and allodynia. Glycine has an inhibitory effect on
dorsal horn neurons by promoting chloride ion conductance,
leading to membrane hyperpolarisation (Yoshimura and Nishi
1995). Removing this inhibition may lead to neuroexcitation,
which could manifest as myoclonus and hyperalgesia. However,
in vitro studies (Bartlet and others 1994) have failed to demon-
strate binding of morphine or M-3-G to glycine receptors,
throwing doubt on this theory. Another hypothesis is that mor-
phine or M-3-G indirectly activates N-methyl D-aspartate
(NMDA) receptors thereby causing excitation. Hempstadt and
others (2003) demonstrated in vitro activation of NMDA recep-
tors by M-3-G on rat hippocampal neurons.
It was reported that similar adverse effects were not seen when
alternative opioids, such as methadone and sufentanil, are adminis-
tered (Yaksh and others 1986). These do not undergo signiﬁcant
glucuronidation, adding weight to the theory that M-3-G is
responsible for the adverse neurological effects seen. Methadone
has been used as an alternative to morphine when myoclonus or
hyperalgesia has been observed in human patients, resulting in
resolution of the adverse effects (Sjogren and others 1994). It has
NMDA antagonist properties, and so in theory should attenuate
neuroexcitatory effects, if they are mediated by NMDA receptor
activity. Recently, however, methadone has been reported to cause
myoclonus at high doses (Ito and Liao 2008) in humans, which
was speculated to be due to its activity at delta receptors.
Stimulation of delta receptors has been shown to induce myo-
clonic contractions in rats when injected directly into the ventricles
(Dzoljic and Poel-Heisterkamp 1982). Methadone’s effects on
delta receptors were hypothesed to predominate over NMDA
antagonist effects when given in high doses leading to myoclonus
(Ito and Liao 2008). Interestingly, in the same study by Dzoljic and
Poel-Heisterkamp (1982), morphine injected intraventricularly
failed to produce myoclonic contractions in rats. These conﬂicting
ﬁndings highlight that more work is still needed to determine the
exact pathogenesis by which opioids can produce neuroexcitation.
Morphine used in this case contained sodium metabisulphite
as preservative. It is generally recommended to use preservative-
free solutions in epidurals to eliminate the risk of toxic effects
of preservatives on the spinal cord, if inadvertent intrathecal
injection is performed (Valverde 2008). However, morphine
with sodium metabisulphite has not been shown to produce any
adverse clinical signs or neuropathology when given to dogs as
a single epidural dose (King and others 1984) or when
chronically administered intrathecally to people (Sjoberg and
others 1992). Therefore, it was not felt that the use of this pre-
servative contributed to the clinical signs in this case.
An important difference when compared with two similar
reported cases in dogs by Kona-Boun and others (2003) and Da
Cunha and others (2007) is that, in this patient, myoclonus
resolved under inhalational anaesthesia with isoﬂurane.
Treatment in this case consisted of intravenous methadone,
which has been successful in resolving cases of opioid induced
hyperalgesia and myoclonus in human patients (Sjogren and
others 1994). This is thought to be due to either its lack of
active metabolites or NMDA receptor antagonist actions.
Medetomidine, an alpha 2 adrenoreceptor agonist, was also
given, and it may have contributed to resolution of myoclonus
due to its centrally acting muscle relaxation as another alpha 2
agonist, tizanide, has been found to resolve muscle spasticity in
humans (Nance and others 1994).
Other possible treatments include benzodiazepines that have
been used successfully to treat myoclonus following perioperative
spinal opioid administration in humans (Bamgbade and others
2009) and dogs (Iff and others 2012). When used in a case of
intrathecal morphine overdose in a dog (Da Cuhna and others
2007), effects quickly diminished with repeated doses until no
effect was seen. Ketamine, an NMDA receptor antagonist, has
also been reported to resolve hyperalgesia and myoclonus follow-
ing chronic intrathecal opioid administration in a person when
given as a low dose infusion (Forero and others 2011).
Experimentally, a systemic bolus of ketamine resolved morphine
induced hindlimb myoclonus in mice (Kolesnikov and others
1997). However, it was unsuccessful in resolving neuroexcitation
in a dog following a perioperative dose of intrathecal morphine
(Iff and others 2012). Both of these could have been used as add-
itional medication in this patient if clinical signs persisted.
Naloxone has been shown to be ineffective in a number of cases
(Werz and MacDonald 1982, Da Cuhna and others 2007), which
is possibly because the neuroexcitatory effects of morphine are
not opioid receptor medicated (Werz and MacDonald 1982). A
number of other medications have been used in existing case
reports involving dogs and include intravenous phenobarbitone,
pentobarbitone, atracurium, acepromazine and butorphanol with
varying degrees of success (Kona-Boun and others 2003, Da
Cuhna and others 2007, Iff and others 2012).
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